Manipal Hospitals
| India | Turchia | Austria | |
| Radioterapia per il cancro colorettale | da $3,200 | da $7,000 | da $12,000 |
| Radiochirurgia stereotassica | da $5,200 | da $4,500 | da $17,000 |
| Craniotomia | da $5,733 | da $5,650 | da $20,000 |
| Chemioterapia per carcinoma mammario | da $3,500 | da $1,200 | da $15,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Medulloblastoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Medulloblastoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Medulloblastoma.
Il medico si è laureato in Medicina presso l'Università di Mysore nel 1996, seguito da un Dottorato in Medicina in radioterapia presso l'Università Hindu di Banaras nel 2002. Per migliorare ulteriormente la sua esperienza, il medico ha conseguito un Diploma del Consiglio Nazionale in radioterapia nel 2004.<\/p>
Il medico è membro di diverse organizzazioni prestigiose, tra cui l'Associazione di Oncologia Radioterapica dell'India, la Società di Neuro-Oncologia, il Gruppo di Oncologia di Bangalore e l'Associazione Indiana di Oncologia Ipertermica, riflettendo un forte impegno per l'avanzamento del campo dell'oncologia.<\/p>
Il medico è uno specialista esperto in medicina nucleare presso l'HCG Manavata Cancer Centre con 12 anni nel campo. Il medico si specializza in vari esami nucleari, esami PET-CT e servizi di cardiologia nucleare, dimostrando competenza nelle terapie con radioiodio e Lu-177 RN. Nel corso della sua carriera, il medico ha gestito oltre 30.000 esami PET e trattato oltre 1.000 pazienti con cancro alla tiroide. Inoltre, il medico ha contribuito al campo attraverso articoli pubblicati in varie riviste mediche.<\/p>
La dottoressa è un'oncologa altamente qualificata specializzata nel trattamento di vari tipi di cancro, inclusi tumori solidi, tumori pediatrici e malignità ematologiche. È esperta in trattamenti sia conservativi che chirurgici, come la procedura di Whipple.<\/p>
Ha completato il suo MBBS al Lady Hardinge Medical College e il MD in medicina interna al Maulana Azad Medical College. Ha proseguito con il DM in Oncologia Medica al Tata Memorial Hospital, dove ha anche lavorato come consulente.<\/p>
È affiliata a società oncologiche internazionali e nazionali e ha esperienza in tumori polmonari, mammari, ginecologici e genitourinari, con un particolare interesse per l'immunoterapia e la terapia metronomica.<\/p>
Medulloblastoma treatment in India follows multi-modal protocols including maximal safe surgical resection, risk-stratified craniospinal irradiation, and systemic chemotherapy. Indian centers utilize advanced Volumetric Modulated Arc Therapy and Proton Beam Therapy. Treatment intensity is adjusted based on age, tumor residual, and molecular subtyping.
Bookimed Expert Insight: Quality of care in India is concentrated in high-volume oncology clusters like Chennai and Gurgaon. Clinics such as Global Hospital Chennai and Fortis Gurgaon utilize linear accelerators with 1 mm accuracy. These facilities serve up to 80,000 patients annually. This high volume ensures surgeons maintain the precision required for complex posterior fossa resections.
Patient Consensus: Patients emphasize the need for large tertiary cancer centers over smaller hospitals for this complex surgery. They note that long-term follow-up must include regular hearing checks and neurodevelopment monitoring.
Indian specialists achieve cure rates of 70% to 85% for standard-risk medulloblastoma in children. Success depends on early diagnosis and complete surgical removal. Major centers in India follow international neuro-oncology protocols. These combine precision neurosurgery, craniospinal radiation, and intensive chemotherapy.
Bookimed Expert Insight: India has become a global hub for neuro-oncology because it offers high-volume clinical expertise at facilities like HCG Manavata Cancer Centre. This clinic has treated over 100,000 patients and maintains a staff of 40+ oncologists. For medulloblastoma, success is linked to the surgeon’s experience. Dr. Raj Nagarkar has performed over 50,000 surgeries, showing the deep technical skill available in Indian specialized centers.
Patient Consensus: Patients emphasize that receiving a second opinion is vital to confirm risk stratification. They often highlight that while treatment is effective, focusing on long-term rehabilitation for side effects like fatigue is necessary.
Medulloblastoma treatment risks include neurological deficits from surgery, hearing loss from chemotherapy, and hormonal imbalances after radiation. Long-term side effects often manifest as cognitive delays, growth deficiencies, and impaired coordination. Specialized Indian centers utilize linear accelerators with 1mm accuracy to minimize damage to healthy brain tissue.
Bookimed Expert Insight: Coordination of care is the most critical factor for long-term outcomes in India. Top-tier facilities like Global Hospital Chennai and HCG Manavata Cancer Centre integrate pediatric oncology with specialized audiology and endocrinology. Choosing a center with these built-in support services ensures early detection of late effects like hearing loss or growth hormone deficiency without needing separate referrals.
Patient Consensus: Patients note it is vital to request baseline hearing tests before starting chemotherapy and to emphasize fertility preservation early. Families frequently highlight that daily stamina and school performance may lag even when follow-up scans show clear results.
Medical centers in Chennai, Gurgaon, Mumbai, and Bengaluru offer high-level expertise for medulloblastoma treatment. These hubs feature specialized pediatric tumor boards and advanced neuro-navigation. Facilities like Apollo Proton Cancer Centre and HCG Cancer Hospital provide precision radiation essential for protecting developing tissues.
Bookimed Expert Insight: Patient volume data often reveals hidden specializations. While many associate Gurgaon with adult transplants, Medanta manages 20,000 patients annually with a heavy focus on complex neuro-oncology imaging. For pediatric cases, choosing a facility like HCG Manavata, which manages 75,000 patients yearly, ensures access to doctors like Dr. Shruti Kate who have specific training from India's apex cancer institutes.
Patient Consensus: Families emphasize finding a hospital that coordinates surgery, radiation, and chemotherapy in one location. Many recommend getting a second pathology opinion from major metro centers to confirm the specific tumor subtype before starting treatment.
International families should plan a stay of 7 to 10 months for complete medulloblastoma treatment in India. This duration covers surgery, craniospinal radiation, and maintenance chemotherapy. Families can reduce this stay to approximately 3 months by completing the final chemotherapy phase in their home country.
Bookimed Expert Insight: Choosing centers with integrated research and high patient volumes, such as HCG Manavata Cancer Centre which serves 75,000 patients annually, ensures access to specialists like Dr. Shruti Kate who have specific pediatric oncology training. High-volume Indian centers often provide more stable scheduling for complex, multi-phase treatments which helps prevent delays in the 7-month timeline.
Patient Consensus: Families emphasize that the stay is a marathon rather than a sprint, often requiring a `just in case` time cushion for neurologic assessments and pathology reviews. Most suggest booking furnished apartments with kitchens because preparing hygienic, home-cooked meals is vital for children during long chemotherapy cycles.